Tiger Brokers

Dexcom Reports Higher Profit, Raises FY Sales Outlook

Dow Jones
Jul 31

Dexcom reported higher profit and revenue in the second quarter as demand for its continuous glucose monitors grew in the U.S. and internationally.

The diabetes-device maker reported a profit of $249.1 million, or 64 cents a share, compared with a profit of $179.8 million, or 45 cents a share, a year earlier.

Adjusted earnings were 70 cents a share, compared with analysts' expectations of 61 cents a share, according to FactSet.

Revenue rose 13% to $1.31 billion. Analysts polled by FactSet expected $1.29 billion.

Dexcom said U.S. revenue rose 11% and international revenue rose 19% year over year.

For the full year, the company expects revenue of $5.18 billion to $5.25 billion, up from $5.16 billion to $5.25 billion previously.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10